Showing results 2 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Reply Journal:Hepatology | 2022 | ||
RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy Proceeding/Conference:Journal of Hepatology | 2020 |